Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells

Lignende værker

• Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
  af: You, Kyu Sic, et al.
  Udgivet: (2021)
• Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6
  af: YI, YONG WEON, et al.
  Udgivet: (2015)
• Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells
  af: Yi, Yong Weon, et al.
  Udgivet: (2013)
• An increased cell cycle gene network determines MEK and Akt inhibitor double resistance in triple-negative breast cancer
  af: van der Noord, Vera E., et al.
  Udgivet: (2019)
• Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer
  af: Kim, Min Woo, et al.
  Udgivet: (2019)